Orange Book product · Generic (ANDA)
E.E.S. 400
ERYTHROMYCIN ETHYLSUCCINATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN ETHYLSUCCINATE
Strength
EQ 400MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 061905
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN ETHYLSUCCINATE
- —E.E.S.Brand (NDA)
NDA 050207 · CARNEGIE
- —E.E.S.Brand (NDA)
NDA 050297 · AZURITY
- 2022ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 216212 · CADILA PHARMS LTD
- 2019ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 211204 · AMNEAL PHARMS
- 2019ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 211991 · PH HEALTH
- 1988ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062847 · AUROBINDO PHARMA USA
- 1987ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062674 · NASKA
- 1985ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062559 · PHARMAFAIR
- 1985ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062558 · PHARMAFAIR
- —ERYTHROMYCIN ETHYLSUCCINATEGeneric (ANDA)
ANDA 062055 · ANI PHARMS
- —PEDIAMYCINGeneric (ANDA)
ANDA 062305 · ROSS LABS
- —E-MYCIN EGeneric (ANDA)
ANDA 062198 · PHARMACIA AND UPJOHN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
